Chronic Pain
Anti-Inflammatories: Good or Bad for Acute Pain?
The answer to this question may seem like a no-brainer. But a new study is calling the decades-long treatment of anti-inflammatory drugs for acute pain into question. Researchers from McGill University in Montreal have turned acute pain care on its head. Their study, published in Science Translational Medicine, revealed thatRead
Pain Tracker Assessment Proves Positive for Patients with Chronic Pain
Pain, it’s a national epidemic. This study supports what you already know: People in chronic pain are some of the most difficult patients to treat. Pain is complex and the circumstances that lead to chronic pain are not easy to remedy. This study from University Washington’s Medicine Center for PainRead
Interview with Bernard Bihari, MD: Low-dose Naltrexone for Normalizing Immune System Function
Introduction Bernard Bihari, MD, (1931-2010) was the discoverer of the clinical effects of low-dose naltrexone (LDN) in humans. In his groundbreaking clinical trial of patients with HIV/AIDS at Downstate Medical Center in 1985-86, Dr Bihari discovered the significant effectiveness of low-dose naltrexone in protecting the battered immune systems
